Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Blood Coagulation Disorders; Hemostatic Disorders; Sepsis; Toxemia | Phase 3 | ClinicalTrials |
| Fibrosis; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis | Phase 3 | ClinicalTrials |
| Disseminated Intravascular Coagulation; Sepsis; Toxemia | Phase 2 | ClinicalTrials |
| Disseminated Intravascular Coagulation | Phase 4 | ClinicalTrials |
| Blood Coagulation Disorders; Hemostatic Disorders; Sepsis; Toxemia | Phase 3 | ClinicalTrials |
CONTENTS